Top drug regulator looks to fix approval process anomaly for first innovator

The CDSCO aims to rectify discrepancies in India's drug approval process that puts initial applicants at disadvantage, leading to delays and inequities. Stakeholder feedback will be sought to establish a balanced policy, crucial for the growth of India's $50 billion pharmaceutical sector.